BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1040 related articles for article (PubMed ID: 1678565)

  • 41. The role of calcium antagonists in the treatment of myocardial ischemia.
    Follath F
    Am Heart J; 1989 Nov; 118(5 Pt 2):1093-6; discussion 1096-7. PubMed ID: 2683702
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Problems of combined therapy with cardiac glycosides and anti-anginal drugs (author's transl)].
    Klaus W
    Arzneimittelforschung; 1977; 27(3a):731-6. PubMed ID: 17417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug treatment of stable angina pectoris in the elderly: defining the place of calcium channel antagonists.
    Kumar S; Hall RJ
    Drugs Aging; 2003; 20(11):805-15. PubMed ID: 12964887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Choosing the most appropriate treatment for stable angina. Safety considerations.
    Asirvatham S; Sebastian C; Thadani U
    Drug Saf; 1998 Jul; 19(1):23-44. PubMed ID: 9673856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ranolazine (Ranexa) for chronic stable angina.
    Ndegwa S
    Issues Emerg Health Technol; 2007 Jun; (99):1-6. PubMed ID: 17595750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stable angina pectoris: the medical management of symptomatic myocardial ischemia.
    Parker JD; Parker JO
    Can J Cardiol; 2012; 28(2 Suppl):S70-80. PubMed ID: 22424287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calcium antagonists for Prinzmetal's variant angina, unstable angina and silent myocardial ischemia: therapeutic tool and probe for identification of pathophysiologic mechanisms.
    Stone PH
    Am J Cardiol; 1987 Jan; 59(3):101B-115B. PubMed ID: 3544788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium-blocker therapy for unstable angina pectoris.
    Zelis R
    N Engl J Med; 1982 Apr; 306(15):926-8. PubMed ID: 6121290
    [No Abstract]   [Full Text] [Related]  

  • 49. [Anti-angina effect of amiodarone in therapy-resistant angina pectoris].
    Meyer BJ; Gschwend S; Marx B; Amann FW
    Schweiz Med Wochenschr; 1992 Jan; 122(3):70-2. PubMed ID: 1346342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Beta receptor blockers and calcium antagonists in coronary disease. Differential therapeutic aspects].
    Delius W
    Dtsch Med Wochenschr; 1983 Jul; 108(30):1154-8. PubMed ID: 6140156
    [No Abstract]   [Full Text] [Related]  

  • 51. Rational medical therapy for stable angina pectoris.
    Hoekenga D; Abrams J
    Am J Med; 1984 Feb; 76(2):309-14. PubMed ID: 6141729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The treatment of stable angina pectoris.
    GarcĂ­a-Palmieri MR
    Postgrad Med J; 1992; 68 Suppl 1():S61-4. PubMed ID: 1357641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined use of calcium-channel and beta-adrenergic blockers for the treatment of chronic stable angina. Rationale, efficacy, and adverse effects.
    Strauss WE; Parisi AF
    Ann Intern Med; 1988 Oct; 109(7):570-81. PubMed ID: 2901816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
    McClellan KJ; Plosker GL
    Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical evaluation of calcium-antagonist drugs.
    Ghio S; Specchia G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S71-4. PubMed ID: 1284160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of antianginal drugs in stable angina on predicted mortality risk after surviving a myocardial infarction: a preliminary study (METRO).
    Iyengar SS; Rosano GM
    Am J Cardiovasc Drugs; 2009; 9(5):293-7. PubMed ID: 19791838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacologic management of ischemic heart disease with beta-blockers and calcium channel blockers.
    Pearle DL
    Am Heart J; 1990 Sep; 120(3):739-42; discussion 743-5. PubMed ID: 1975155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of nitrates for the therapy of coronary artery disease patients in the years beyond 2000.
    Darius H
    J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 2():S15-20; discussion S29-31. PubMed ID: 10499556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris.
    Leon MB; Rosing DR; Bonow RO; Epstein SE
    Am J Cardiol; 1985 Jan; 55(3):69B-80B. PubMed ID: 2857518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-dose monotherapy and combination therapy with calcium channel blockers for angina. A comprehensive review of the literature.
    Temkin LP
    Am J Med; 1989 Jan; 86(1A):23-7. PubMed ID: 2563636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.